NTRB
Nutriband Inc
$
7.170
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
7.780
Open
7.230
VWAP
7.33
Vol
3.16M
Mkt Cap
79.98M
Low
6.8801
Amount
23.16M
EV/EBITDA(TTM)
--
Total Shares
11.04M
EV
77.19M
EV/OCF(TTM)
--
P/S(TTM)
33.18
Nutriband Inc. is engaged in the development of a portfolio of transdermal pharmaceutical products. Its development pipeline consists of transdermal products that are based on proprietary AVERSA abuse-deterrent transdermal technology. Its lead product under development is AVERSA Fentanyl, an abuse deterrent fentanyl transdermal system that combines an approved generic fentanyl patch with its AVERSA abuse deterrent transdermal technology to reduce the abuse and misuse of fentanyl patches. Its development pipeline also includes AVERSA Buprenorphine and AVERSA Methylphenidate. It is developing a portfolio of transdermal pharmaceutical products to deliver already approved drugs or biologics that are typically delivered by injection but with the potential to improve compliance and therapeutic outcomes through transdermal delivery. AVERSA technology can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.
Show More
1 Analyst Rating
109.21% Upside
Wall Street analysts forecast NTRB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NTRB is 15.00 USD with a low forecast of 15.00 USD and a high forecast of 15.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
109.21% Upside
Current: 7.170
Low
15.00
Averages
15.00
High
15.00
109.21% Upside
Current: 7.170
Low
15.00
Averages
15.00
High
15.00
Noble Capital Markets
Robert LeBoyer
Buy
Initiates
$13
2025-01-22
Reason
Noble Capital Markets
Robert LeBoyer
Price Target
$13
2025-01-22
Initiates
Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Nutriband Inc (NTRB.O) is -260.73, compared to its 5-year average forward P/E of -4.13. For a more detailed relative valuation and DCF analysis to assess Nutriband Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-4.13
Current PE
-260.73
Overvalued PE
143.98
Undervalued PE
-152.23
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
3.22
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
76.98
Undervalued EV/EBITDA
-70.54
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
18.10
Current PS
0.00
Overvalued PS
40.02
Undervalued PS
-3.82
Financials
Annual
Quarterly
FY2026Q1
YoY :
+63.37%
667.43K
Total Revenue
FY2026Q1
YoY :
-25.19%
-1.41M
Operating Profit
FY2026Q1
YoY :
-26.83%
-1.39M
Net Income after Tax
FY2026Q1
YoY :
-42.86%
-0.12
EPS - Diluted
FY2026Q1
YoY :
+59.77%
-1.34M
Free Cash Flow
FY2026Q1
YoY :
-6.42%
37.75
Gross Profit Margin - %
FY2026Q1
YoY :
+19.72%
-217.67
FCF Margin - %
FY2026Q1
YoY :
-55.21%
-208.09
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
NTRB News & Events
Events Timeline
2025-08-11 (ET)
2025-08-11
05:07:00
Nutriband CEO Gareth Sheridan steps aside for Irish election
2025-08-08 (ET)
2025-08-08
08:06:12
Nutriband announces FDA granted Type C Meeting for AVERSA FENTANYL
2025-07-18 (ET)
2025-07-18
09:18:32
Nutriband confirms record, pay date for 25% preferred stock dividend
Sign Up For More Events
Sign Up For More Events
News
5.0
09:00 AMNASDAQ.COMNutriband CEO Steps Down Temporarily; FDA Meeting Granted For AVERSA Fentanyl
5.0
09:00 AMNewsfilterNutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election
9.0
08-08NewsfilterFDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch
Sign Up For More News
People Also Watch
MNY
MoneyHero Ltd
1.760
USD
+2.33%
TACT
TransAct Technologies Inc
3.960
USD
+4.21%
FAAS
DigiAsia Corp
0.294
USD
+1.72%
ASRV
Ameriserv Financial Inc
2.900
USD
-0.68%
KZR
Kezar Life Sciences Inc
4.005
USD
+0.63%
MOBX
MOBIX LABS, INC.
0.957
USD
+10.00%
KELYB
Kelly Services Inc
11.910
USD
-8.38%
FORL
Four Leaf Acquisition Corp
11.522
USD
-3.50%
CCLD
CareCloud Inc
2.675
USD
+8.30%
FAQ
What is Nutriband Inc (NTRB) stock price today?
The current price of NTRB is 7.17 USD — it has increased 0.56 % in the last trading day.
What is Nutriband Inc (NTRB)'s business?
What is the price predicton of NTRB Stock?
What is Nutriband Inc (NTRB)'s revenue for the last quarter?
What is Nutriband Inc (NTRB)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Nutriband Inc (NTRB)'s fundamentals?
How many employees does Nutriband Inc (NTRB). have?